Platelet-Rich Plasma (PRP)
Concentrated autologous platelets delivered under ultrasound guidance to accelerate soft-tissue healing in tendons, ligaments, and early joint disease.
What It Is / How It Works
Platelet-Rich Plasma is derived from a small sample of the patient's own blood. After centrifugation, platelets are concentrated 3–10x above baseline levels. This concentrate is rich in growth factors — including PDGF, TGF-β, VEGF, and IGF-1 — that signal tissue repair, reduce inflammation, and promote angiogenesis at the treatment site. PRP is delivered via ultrasound-guided injection directly to the area of pathology, ensuring precise placement and minimizing procedural risk.
PRP is autologous — meaning derived from the patient's own biology — eliminating concerns about immune rejection or disease transmission. It represents a first-line biologic option for patients seeking alternatives to corticosteroid injections, which can cause tissue degradation with repeated use.
Who Is a Candidate
What to Expect
Evidence Base
Interested in learning whether this treatment is appropriate for you?
Request a Consultation ↗